HBM Healthcare Investments discloses 12.5% stake in Chemomab ahead of merger
HBM Healthcare Investments (Cayman) Ltd. disclosed beneficial ownership of 80,971,680 ordinary shares, or 12.5% of Chemomab Therapeutics Ltd., in connection…
12.5%shares81.0Mshares